 |
 |  | 
 March 2007 FDA meeting
 Ann Fonfa's comments on Sentinel Network Maryann Napoli's comments on FDA Issues
|  |  |  | 
 Dietary Supplements
 CNN Article 4/12/01 Dietary Supplement Health & Educ Act of 1994 Testimony 6/8/99
|
 |
 |
 |  | 
 Posted February 2007
Advocate Helen Schiff, NYC

|  |  |  | 
 Arch Intern Med, 2006

|
 |
 |
 |  | 
 FDA ODAC Hearing, 9/06/06

|  |  |  | 
 Amazing discussion: Time To Progression
 Ann's Testimony Epirubicin and FDA Panel
|
 |
 |
 |  | 
 Exerpts from FDA summary
www.fda.gov
 Reuters Health Coverage of this FDA Meeting Accelerated Approval-Statement of Maryann Napoli
|  |  |  | 
 USA Today reports
54% have interest in drug/topic
being evaluated 9/00
 Proposals for Public Disclosure of Advisory Panel Members FDA Scientists Pressured to Exclude, Alter Findings
|
 |
 |
 |  | 
 Ann's testimony via letter,
2001

|  |  |  | 
 December 14, 2000
Discussion & Patient/Pharmaceutical
Testimony
 Ann Fonfa's Testimony Melissa Yazman Testimony Chelsea Kidd Testimony
|
 |
 |
 |  | 
 August 2001

|  |  |  | 
 July, 2001
Reuters Health

|
 |
 |
 |  | 
 December 2001
 FDA Okays Speedier Medication Reviews FDA Rule Changes: Benefits/Dangers
|  |  |  | 
 January 2002

|
 |
 |
 |  | 
 Boston Globe, 3/21/02
 Industry Influence on Federal Advisory Committees Letter to Dr. Lester Crawford, FDA Acting Commissioner
|  |  |  | 
 Press Release Health Action Int'l
6/19/02

|
 |
 |
 |  | 
 Letter in Support of Senator Durbin,
Representative Hinchey
June 8, 2005

|  |  |  | 
 FDA Comment period until March 14, 200

|
 |
 |
 |  | 
 New York Times, May 9, 2007

|  |  |  | 
 Perspective and summary from
Sharon Batt, a Canadian activist
 Ann Fonfa's Testimony to the FDA 9/2/98 Washington Post Coverage, 9/98
|
 |